CMTA Announces Participation in Seed Extension Round for Armatus Bio for Novel CMT1A Gene Therapy
The Charcot-Marie-Tooth Association (CMTA) today announced that it participated in the Seed Series Extension syndicate for Armatus Bio, Inc. (Armatus). Armatus is an emerging Biotechnology...
CMTA Appoints Biotech Industry Veteran Suzanne Bruhn, PhD as New CEO
The Charcot-Marie-Tooth Association announced Nov. 6 that Suzanne (Sue) Bruhn, PhD, an accomplished biotech executive with extensive experience in the development and commercialization of treatments...
Charcot-Marie-Tooth Association: Sperm Donor With CMT Gene Passes It on to Multiple Families
The letter from the sperm bank landed like a bomb in the midst of the families who had conceived children with Donor X: He had...